LMG Life Sciences Awards EMEA 2024: shortlist revealed
Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2024: shortlist revealed

LMG Life Sciences EMEA Awards 2024 Shortlist Announced 1200x627@4x.png

The LMG Life Sciences Awards is thrilled to present the shortlist for the 2024 EMEA Awards.

The LMG Life Sciences Awards has released the full list of finalists for the 2024 Europe, Middle East, and Africa Awards. These awards bring together the region’s legal community to recognise the leading law firms and attorneys to celebrate the successes in the Life Sciences industry.

The winners will be announced at a black-tie gala celebration on 16 May 2024 at the Waldorf Hilton in London.

The LMG Life Sciences Awards research team carefully selected each finalist after a thorough research period which included an analysis of direct submissions, client feedback, and heavy deliberation. Individual practitioners and Rising Stars are judged not only on the complexity of their work but also on their thought leadership.

All the work accepted to be shortlisted closed during the research period, 1 January to 31 December 2023. The awards do not recognise cases, deal, or other matters completed outside of the research period.

If you have any questions regarding our research process, please contact our editor, John Harrison.

The LMG Life Sciences Awards will be announcing winners on 16 May 2024 at a live awards gala. To find out more about the gala and how you can promote your success, please contact George Reeves.

Now without further ado…

Preview of the Intellectual Property shortlisted categories for 2024

Accordion override

Firm Awards

  • Patent Litigation Firm of the Year - Biologics / Biosimilars

    Bird & Bird
    Carpmaels & Ransford
    DLA Piper
    Liad Whatstein & Co
    Powell Gilbert
    Wolf Theiss
  • Patent Litigation Firm of the Year - Medical Devices

    Bird & Bird
    Carpmaels & Ransford
    NSN Law Firm
    Powell Gilbert
    Schellenberg Wittmer
    Taylor Wessing
  • Patent Strategy Firm of the Year

    Carpmaels & Ransford
    Dimitrov Petrov & Co
    Doubinsky & Osharova
    Herbert Smith Freehills
    NSN Law Firm
    The Luzzatto Group
  • Patent Litigation Firm of the Year - Biotech

    Bird & Bird
    Carpmaels & Ransford
    DLA Piper
    Powell Gilbert
    Wolf Theiss
  • Patent Litigation Firm of the Year - Pharmaceuticals

    A&O Shearman
    Carpmaels & Ransford
    Crowell & Moring
    Gün + Partners
    Hogan Lovells
    Powell Gilbert
  • SPC Litigation Firm of the Year

    A&O Shearman
    Bird & Bird
    DLA Piper
    Sérvulo & Associados
    Taylor Wessing

Individual Awards

  • Patent Litigator of the Year - Biologics / Biosimilars

    Andreas Seling, DORDA
    Aoife Murphy, DLA Piper
    David Wilson, Carpmaels & Ransford
    Ignacio Pontijas, Grau & Angulo
    Kfir Luzzatto, The Luzzatto Group
    Marc van Wijngaarden, Bird & Bird
    Penny Gilbert, Powell Gilbert
  • Patent Litigator of the Year - Medical Devices

    Andrew Wells, Herbert Smith Freehills
    Ian Kirby, Carpmaels & Ransford
    Irene Picciano, Portolano Cavallo
    Jochen Herr, Finnegan
    Maier Fenster, Ehrlich Group
    Morag Macdonald, Bird & Bird
    Sidd Kusumakar, Powell Gilbert
  • Patent Strategy & Management Lawyer of the Year

    Emanuel Manzurola, The Luzzatto Group
    Jake Marshall, Carpmaels & Ransford
    Kerim Emre Yardimci, DERIS
    Marianne Schaffner, Reed Smith
    Mark S Cohen, Pearl Cohen
    Vitalii Savchuk, Legal Alliance
    Zoe Butler, Powell Gilbert
  • IP Rising Star

    Alara Naçar Seçkin, NSN Law Firm
    Carlos van Staveren, Bird & Bird
    Daria Romashchenko, Aequo
    K Victoria Barker, Finnegan
    Marie Keup, Taylor Wessing
    Soley Coban, DERIS
    Yana Georgieva, Dimitrov Petrov & Co
  • Patent Litigator of the Year - Biotech

    Ann De Clercq, De Clercq & Partners
    Hadassa Waterman, Ehrlich Group
    Ignacio Pontijas, Grau & Angulo
    Jennifer Antcliff, Carpmaels & Ransford
    Jennifer Jones, Bird & Bird
    Penny Gilbert, Powell Gilbert
    Wim Maas, Taylor Wessing
  • Patent Litigator of the Year - Pharmaceuticals

    Gülay Göksu Anul, NSN Law Firm
    Hugo Monteiro de Queirós, PLMJ
    Laëtitia Bénard, A&O Shearman
    Laura Orlando, Herbert Smith Freehills
    Nataliya Dryuk, Aequo
    Penny Gilbert, Powell Gilbert
    Tal Band, S Horowitz & Co
  • SPC Litigator of the Year

    Ana Rita Paínho, Sérvulo & Associados
    Aoife Murphy, DLA Piper
    Charles Tuffreau, A&O Shearman
    Christian Dekoninck, Taylor Wessing
    Eleanor Root, Bird & Bird
    Ignacio Pontijas, Grau & Angulo
    Rainer Hilli, Roschier

LMG Life Sciences is a sister publication to Managing IP, and is run independently from IPSTARS research.

more from across site and ros bottom lb

More from across our site

View the Social Impact EMEA Awards 2024 shortlist and join us on September 12 at The Waldorf Hotel in London
James Tumbridge talks about advising the government on AI and why his day could start with the police and end with legal networking
Data from Managing IP+’s Talent Tracker shows that the IP ambitions of Asian full-service firms and a life sciences focus in the US have prompted lateral moves
Michelle Lue-Reid has joined the IP business as its chief transformation officer and will look to implement major change initiatives across member firms
Chad Landmon, who joins in Washington DC, hopes to expand the firm’s Hatch-Waxman practice
The FRAND rate is only 5 cents higher than the per-device rate determined at first instance in 2023
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Nearly four months after joining Crowell & Moring, Edward Taelman reflects on starting afresh, new clients, and firm culture
Firms discuss the ebb and flow of life sciences IP work and explain how they help professionals pivot between specialities
Mercedes-Benz, Dolby Laboratories, and Panasonic discuss the merits and drawbacks of the USPTO's terminal disclaimer proposal
Gift this article